| Primary |
| Drug Use For Unknown Indication |
53.7% |
| Hypertension |
10.6% |
| Prophylaxis |
4.1% |
| Type 2 Diabetes Mellitus |
4.1% |
| Angina Pectoris |
3.3% |
| Myocardial Ischaemia |
2.4% |
| Premedication |
2.4% |
| Arrhythmia |
1.6% |
| Arterial Stent Insertion |
1.6% |
| Atrial Fibrillation |
1.6% |
| Blood Pressure Increased |
1.6% |
| Cardiac Failure Congestive |
1.6% |
| Cholelithiasis |
1.6% |
| Dyspepsia |
1.6% |
| Essential Hypertension |
1.6% |
| Hypercholesterolaemia |
1.6% |
| Respiratory Tract Infection |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Atonic Seizures |
0.8% |
| Atrial Septal Defect |
0.8% |
|
| Thrombocytopenia |
11.1% |
| Acute Prerenal Failure |
7.4% |
| Melaena |
7.4% |
| Renal Failure Acute |
7.4% |
| Toxic Epidermal Necrolysis |
7.4% |
| Vomiting |
7.4% |
| Anaemia Haemolytic Autoimmune |
3.7% |
| Diabetes Mellitus |
3.7% |
| Duodenal Ulcer Haemorrhage |
3.7% |
| Gastrointestinal Haemorrhage |
3.7% |
| Hemiplegia |
3.7% |
| Hepatitis |
3.7% |
| Hepatitis Acute |
3.7% |
| Leukocytoclastic Vasculitis |
3.7% |
| Parotitis |
3.7% |
| Rectal Haemorrhage |
3.7% |
| Renal Failure |
3.7% |
| Respiratory Acidosis |
3.7% |
| Tubulointerstitial Nephritis |
3.7% |
| Upper Gastrointestinal Haemorrhage |
3.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
18.4% |
| Product Used For Unknown Indication |
16.0% |
| Chronic Obstructive Pulmonary Disease |
9.0% |
| Hypertension |
8.6% |
| Cardiomyopathy |
5.7% |
| Cough |
5.7% |
| Prophylaxis |
4.9% |
| Myocardial Ischaemia |
4.1% |
| Acute Myocardial Infarction |
3.7% |
| Atrial Fibrillation |
3.7% |
| Cardiac Disorder |
3.7% |
| Blood Test Abnormal |
2.0% |
| Coronary Artery Disease |
2.0% |
| Diabetes Mellitus |
2.0% |
| Dyslipidaemia |
2.0% |
| Acute Coronary Syndrome |
1.6% |
| Cardiovascular Event Prophylaxis |
1.6% |
| Hypercholesterolaemia |
1.6% |
| Iron Deficiency Anaemia |
1.6% |
| Osteoporosis |
1.6% |
|
| Stevens-johnson Syndrome |
13.7% |
| Suicide Attempt |
9.8% |
| Toxic Epidermal Necrolysis |
9.8% |
| Renal Tubular Necrosis |
7.8% |
| Vomiting |
7.8% |
| Gastrointestinal Haemorrhage |
5.9% |
| Hepatitis Acute |
5.9% |
| Upper Gastrointestinal Haemorrhage |
5.9% |
| Anaemia |
3.9% |
| Diabetes Mellitus |
3.9% |
| Lactic Acidosis |
3.9% |
| Rectal Haemorrhage |
3.9% |
| Treatment Noncompliance |
3.9% |
| Disease Progression |
2.0% |
| Eye Haemorrhage |
2.0% |
| Gastric Ulcer Haemorrhage |
2.0% |
| Hepatitis |
2.0% |
| Hepatitis Cholestatic |
2.0% |
| Hypocoagulable State |
2.0% |
| Infection Parasitic |
2.0% |
|
| Concomitant |
| Hypertension |
19.2% |
| Drug Use For Unknown Indication |
10.8% |
| Osteoporosis |
10.8% |
| Prophylaxis |
9.8% |
| Diabetes Mellitus |
8.5% |
| Cardiac Failure |
4.7% |
| Product Used For Unknown Indication |
4.4% |
| Type 2 Diabetes Mellitus |
4.2% |
| Pain |
4.1% |
| Depression |
3.4% |
| Multiple Myeloma |
3.2% |
| Colorectal Cancer |
2.4% |
| Hypercholesterolaemia |
2.4% |
| Cardiac Disorder |
2.0% |
| Dyslipidaemia |
2.0% |
| Insomnia |
1.8% |
| Myocardial Ischaemia |
1.7% |
| Anxiety |
1.6% |
| Non-small Cell Lung Cancer |
1.6% |
| Atrial Fibrillation |
1.5% |
|
| Renal Failure Acute |
15.1% |
| Vomiting |
7.5% |
| Death |
6.8% |
| Sepsis |
5.5% |
| Hyperkalaemia |
4.8% |
| Hyponatraemia |
4.8% |
| Weight Decreased |
4.8% |
| Aplasia Pure Red Cell |
4.1% |
| Haemoptysis |
4.1% |
| Pulmonary Oedema |
4.1% |
| Respiratory Failure |
4.1% |
| Septic Shock |
4.1% |
| Serotonin Syndrome |
4.1% |
| Somnolence |
4.1% |
| Syncope |
4.1% |
| Therapeutic Agent Toxicity |
4.1% |
| Loss Of Consciousness |
3.4% |
| Pancytopenia |
3.4% |
| Pyrexia |
3.4% |
| Renal Failure |
3.4% |
|
| Interacting |
| Acute Coronary Syndrome |
25.4% |
| Hypertension |
9.2% |
| Prophylaxis |
6.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
6.3% |
| Agitation |
5.6% |
| Angina Pectoris |
5.6% |
| Amnesia |
4.2% |
| Cardiovascular Event Prophylaxis |
4.2% |
| Depression |
4.2% |
| Drug Use For Unknown Indication |
4.2% |
| Acute Myocardial Infarction |
3.5% |
| Atrial Fibrillation |
3.5% |
| Type 2 Diabetes Mellitus |
3.5% |
| Gastritis |
2.1% |
| Hyperlipidaemia |
2.1% |
| Ischaemic Cardiomyopathy |
2.1% |
| Myocardial Ischaemia |
2.1% |
| Pain |
2.1% |
| Thrombosis |
2.1% |
| Dyslipidaemia |
1.4% |
|
| Syncope |
20.6% |
| Hepatitis Cholestatic |
17.6% |
| Upper Gastrointestinal Haemorrhage |
14.7% |
| Drug Interaction |
11.8% |
| Pulmonary Oedema |
8.8% |
| Renal Failure Acute |
8.8% |
| Renal Tubular Necrosis |
5.9% |
| Melaena |
2.9% |
| Subdural Haematoma |
2.9% |
| Thrombotic Thrombocytopenic Purpura |
2.9% |
| Urosepsis |
2.9% |
|
